Anne Schmechtig, PhD

Neuroimaging Institute of Psychiatry, Charleston, SC, United States 
"Anne Schmechtig"
Mean distance: 20.44 (cluster 42)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kumari V, Antonova E, Wright B, et al. (2016) The mindful eye: Smooth pursuit and saccadic eye movements in meditators and non-meditators. Consciousness and Cognition. 48: 66-75
Koychev I, Joyce D, Barkus E, et al. (2016) Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies. Translational Psychiatry. 6: e811
Kumari V, Ettinger U, Lee SE, et al. (2015) Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study. Psychopharmacology
Schmechtig A, Lees J, Perkins A, et al. (2013) The effects of ketamine and risperidone on eye movement control in healthy volunteers. Translational Psychiatry. 3: e334
Perkins AM, Ettinger U, Weaver K, et al. (2013) Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type. Translational Psychiatry. 3: e246
Schmechtig A, Lees J, Grayson L, et al. (2013) Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Psychopharmacology. 227: 331-45
Koychev I, McMullen K, Lees J, et al. (2013) Differential effect of amisulpride on cognition in schizotypy: validation of models for the early identification of cognitive enhancing agents The Lancet. 381: 59-59
Owens SF, Picchioni MM, Ettinger U, et al. (2012) Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain : a Journal of Neurology. 135: 2231-44
Völter C, Riedel M, Wöstmann N, et al. (2012) Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1427-40
Koychev I, McMullen K, Lees J, et al. (2012) A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 469-81
See more...